文献速递慢性肾脏病

自我报告的烟草、酒精及违禁药物使用与慢性肾脏病进展

Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease.
PubMed 文献 · Clin J Am Soc Nephrol · 2018-06-07

在3939例CKD患者的前瞻性队列中,中位随访5.5年,1287例发生CKD进展,1001例死亡。持续使用硬性违禁药物与CKD进展及全因死亡风险升高相关;持续吸烟与全因死亡风险升高相关;持续饮酒与全因死亡风险降低相关。

要点

  • 持续使用硬性违禁药物与CKD进展风险升高相关(HR 1.25)。
  • 持续吸烟与全因死亡风险升高相关(HR 1.86)。
  • 持续饮酒与全因死亡风险降低相关(HR 0.73)。

核心结论

  • 硬性违禁药物使用与CKD进展和全因死亡风险升高相关。
  • 吸烟与全因死亡风险升高相关,饮酒与全因死亡风险降低相关。

研究设计与样本

  • 慢性肾功能不全队列研究(CRIC)为美国前瞻性纵向队列,纳入3939例CKD患者。
  • 基线及年度随访收集自我报告的吸烟、饮酒、大麻及硬性违禁药物使用情况。

主要发现

  • 中位随访5.5年,1287例发生CKD进展,1001例死亡。
  • 基线吸烟、饮酒、大麻使用和硬性违禁药物使用的比例分别为13%、20%、33%和12%。
  • 持续吸烟 vs 不吸烟:CKD进展HR 1.02(95%CI 0.86-1.21),全因死亡HR 1.86(95%CI 1.54-2.24)。
  • 持续饮酒 vs 不饮酒:CKD进展HR 1.06(95%CI 0.88-1.29),全因死亡HR 0.73(95%CI 0.58-0.91)。
  • 持续使用硬性违禁药物 vs 不使用:CKD进展HR 1.25(95%CI 1.00-1.55),全因死亡HR 1.41(95%CI 1.10-1.81)。

关键数值与推荐

  • CKD进展定义为新发ESKD或eGFR减半。
  • 物质使用采用累积平均暴露建模,纳入多变量时间依赖Cox回归。
  • 持续大麻使用 vs 不使用:CKD进展HR 0.94(95%CI 0.82-1.07),全因死亡HR 1.11(95%CI 0.96-1.30)。

临床怎么用

  • 对CKD患者应询问硬性违禁药物使用情况,识别CKD进展和死亡高风险人群。
  • 吸烟与全因死亡风险升高相关,应纳入CKD患者综合管理。
  • 饮酒与全因死亡风险降低相关,但需谨慎解读,不宜据此推荐饮酒。

局限性

  • 物质使用依赖自我报告,可能存在测量偏倚。
  • 观察性设计不能确立因果关系。
  • 饮酒与死亡风险降低的关联可能受混杂因素影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Previous studies suggest that tobacco, alcohol, and illicit drug use is associated with CKD. We examined the associations of substance use with CKD progression and all-cause mortality among patients with CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Chronic Renal Insufficiency Cohort Study is a prospective, longitudinal cohort study among 3939 participants with CKD in the United States. Self-reported tobacco smoking, alcohol drinking, marijuana use, and hard illicit drug (cocaine, heroin, or methamphetamine) use were obtained at baseline and annual follow-up visits. CKD progression was defined as incident ESKD or halving of eGFR. Substance use was modeled as the cumulative average exposure to capture both recent and long-term use in multivariable time-dependent Cox regression. RESULTS: Over a median 5.5-year follow-up, 1287 participants developed CKD progression, and 1001 died. Baseline proportions of tobacco smoking, alcohol drinking, marijuana use, and hard illicit drug use were 13%, 20%, 33%, and 12%, respectively. Compared with nonsmoking throughout follow-up, multivariable-adjusted hazard ratios for persistent tobacco smoking were 1.02 (95% confidence interval, 0.86 to 1.21) for CKD progression and 1.86 (95% confidence interval, 1.54 to 2.24) for all-cause mortality. Compared with nondrinking throughout follow-up, multivariable-adjusted hazard ratios for persistent alcohol drinking were 1.06 (95% confidence interval, 0.88 to 1.29) for CKD progression and 0.73 (95% confidence interval, 0.58 to 0.91) for all-cause mortality. Compared with nonuse throughout follow-up, multivariable-adjusted hazard ratios for persistent marijuana use were 0.94 (95% confidence interval, 0.82 to 1.07) for CKD progression and 1.11 (95% confidence interval, 0.96 to 1.30) for all-cause mortality. Compared with nonuse throughout follow-up, multivariable-adjusted hazard ratios for persistent hard illicit drug use were 1.25 (95% confidence interval, 1.00 to 1.55) for CKD progression and 1.41 (95% confidence interval, 1.10 to 1.81) for all-cause mortality. CONCLUSIONS: Hard illicit drug use is associated with higher risk of CKD progression and all-cause mortality, tobacco smoking is associated with higher risk of all-cause mortality, and alcohol drinking is associated with lower risk of all-cause mortality among patients with CKD.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Bundy JD, Bazzano LA, Xie D, et al. Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease. Clin J Am Soc Nephrol. 2018. PMID: 29880471. doi:10.2215/CJN.11121017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。